Noonan, S. A., Morrissey, M. E., Martin, P., Biniecka, M., Ó'Meachair, S., Maguire, A., . . . O'Sullivan, J. (2018). Tumour vasculature immaturity, oxidative damage and systemic inflammation stratify survival of colorectal cancer patients on bevacizumab treatment. Oncotarget.
Citação norma ChicagoNoonan, Sinead A., et al. "Tumour Vasculature Immaturity, Oxidative Damage and Systemic Inflammation Stratify Survival of Colorectal Cancer Patients On Bevacizumab Treatment." Oncotarget 2018.
MLA引文Noonan, Sinead A., et al. "Tumour Vasculature Immaturity, Oxidative Damage and Systemic Inflammation Stratify Survival of Colorectal Cancer Patients On Bevacizumab Treatment." Oncotarget 2018.
警告：這些引文格式不一定是100％准確.